aTyr Pharma Announces 1-for-40 Reverse Stock Split
Bitget2026/10/27 13:07- aTyr Pharma will implement a 1-for-40 reverse stock split effective at 5 p.m. ET on October 28, 2026.
- Split-adjusted trading will begin October 29, 2026, on the Nasdaq Capital Market under the existing symbol ATYR.
- The consolidation will reduce outstanding common shares from approximately 100,500,000 to 2,500,000.
- The reverse split aims to restore compliance with Nasdaq's minimum bid price requirement for continued listing.
- Fractional shares will be rounded up to whole shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
